Nyxoah S.A. announced that it has appointed Mr. Daniel Wildman as an Independent Director to its Board of Directors. Mr. Wildman is a 40-year veteran of the medical device industry. He is currently the Chairman of the Board of Progenerative Medical Inc. and a Strategic Advisor to several medical device and pharmaceutical companies.

He also serves as member of the Board of Directors of UroGen Pharma Ltd. Mr. Wildman spent most of his career with Johnson & Johnson (“J&J”), where he led the Digital Surgery Strategy Initiative, J&J's DuPuy Synthes Spine franchise and J&J's Ethicon Biosurgery division. Before J&J, Mr. Wildman spent ten years with Boston Scientific Corporation in a variety of sales, marketing, operations, and strategic planning roles.